{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:05:58Z","timestamp":1769126758415,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ahjonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ahj.2016.03.024","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T06:02:01Z","timestamp":1462082521000},"page":"28-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Long-term changes of renal function in relation to ace inhibitor\/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"],"prefix":"10.1016","volume":"178","author":[{"given":"Hanna","family":"Fr\u00f6hlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Nelges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"T\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedat","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Cebola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schnorbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Goode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Frankenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.03.024_bb0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","article-title":"Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.03.024_bb0010","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.024_bb0025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.109.853648","article-title":"Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure","volume":"120","author":"Anand","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.024_bb0030","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease","volume":"153","author":"Berger","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.03.024_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ahj.2004.06.030","article-title":"A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications","volume":"149","author":"Ahmed","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.03.024_bb0040","doi-asserted-by":"crossref","first-page":"70D","DOI":"10.1016\/0002-9149(87)90057-9","article-title":"Influence of renal function on the pharmacokinetics of ramipril (HOE 498)","volume":"59","author":"Debusmann","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00196112","article-title":"Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure. Consequence of dose adjustment","volume":"46","author":"Neubeck","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00679779","article-title":"Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency","volume":"37","author":"Schunkert","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0055","doi-asserted-by":"crossref","first-page":"65D","DOI":"10.1016\/0002-9149(87)90056-7","article-title":"Pharmacokinetics and pharmacodynamics of ramipril in renal failure","volume":"59","author":"Aurell","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejheart.2006.10.003","article-title":"Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure","volume":"9","author":"de Silva","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2016.03.024_bb0065","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.03.024_bb0070","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2016.03.024_bb0075","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.03.024_bb0080","first-page":"1","article-title":"KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ahj.2016.03.024_bb0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2016.03.024_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2016.03.024_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1681\/ASN.2004060447","article-title":"Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease","volume":"16","author":"Poggio","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjmed.2011.10.013","article-title":"Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease","volume":"125","author":"Ahmed","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2016.03.024_bb0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9149(92)91194-9","article-title":"Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial)","volume":"70","author":"Ljungman","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0105","first-page":"216","article-title":"Underutilization of angiotensin converting enzyme inhibitors among heart failure patients","volume":"63","author":"Lean","year":"2008","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.ahj.2016.03.024_bb0110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.165.13.1469","article-title":"Adhere Scientific Advisory Committee SG, Investigators: Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry","volume":"165","author":"Fonarow","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2016.03.024_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/S0066-782X2011005000100","article-title":"ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure","volume":"97","author":"De Vecchis","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.158.1.26","article-title":"Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?","volume":"158","author":"Reardon","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2016.03.024_bb0130","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2012.01.367","article-title":"Predictors of hyperkalemia and death in patients with cardiac and renal disease","volume":"109","author":"Jain","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ejhf.226","article-title":"Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice","volume":"17","author":"Michel","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2016.03.024_bb0140","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ahj.2016.03.024_bb0145","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1681\/ASN.2006050445","article-title":"Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial","volume":"18","author":"Eijkelkamp","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2016.03.024_bb0150","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute Dialysis Quality Initiative: acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.ahj.2016.03.024_bb0155","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T11:23:06Z","timestamp":1536751386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"alternative-id":["S0002870316300382"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.024","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term changes of renal function in relation to ace inhibitor\/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}